• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Gonadorelin Acetate

Gonadorelin Acetate

Product ID G5752
Cas No. 71447-49-9
Purity ≥95%
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Gonadorelin is a synthetic peptide analog of gonadotropin-releasing hormone (GnRH) or luteinizing hormone releasing hormone (LHRH). Gonadorelin acts as an agonist at the GnRH/LHRH receptor, inducing release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). This hormone is clinically used to treat endometriosis. Gonadorelin exhibits anti-androgen and anticancer chemotherapeutic activities. In vitro and in vivo, gonadorelin inhibits testosterone activation of androgen receptors. Additionally, gonadorelin increases proliferation of normal cells but inhibits proliferation of prostate cancer cells through a mechanism that involved activation of the ryanodine receptor and increases in intracellular Ca2+ levels.

Product Info

Cas No.

71447-49-9

Purity

≥95%

Formula

C55H75N17O13 • 2(C2H4O2)

Formula Wt.

1302.59

IUPAC Name

acetic acid;N-[1-[[1-[[1-[[1-[[2-[[1-[[1-[2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide;hydrate

Synonym

Luteinizing hormone-releasing factor acetate, LH-RH

Solubility

Soluble in water, methanol.

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

G5752 MSDS PDF

Info Sheet

G5752 Info Sheet PDF

References

Maudsley S, Davidson L, Pawson AJ, et al. Gonadotropin-releasing hormone functionally antagonizes testosterone activation of the human androgen receptor in prostate cells through focal adhesion complexes involving Hic-5. Neuroendocrinology. 2006;84(5):285-300. PMID: 17202804.

Maiti K, Oh DY, Moon JS, et al. Differential effects of gonadotropin-releasing hormone (GnRH)-I and GnRH-II on prostate cancer cell signaling and death. J Clin Endocrinol Metab. 2005 Jul;90(7):4287-98. PMID: 15870130.

Enomoto M, Park MK. GnRH as a cell proliferation regulator: mechanism of action and evolutionary implications. Zoolog Sci. 2004 Oct;21(10):1005-13. PMID: 15514469.

Shalev E, Leung PC. Gonadotropin-releasing hormone and reproductive medicine. J Obstet Gynaecol Can. 2003 Feb;25(2):98-113. PMID: 12577127.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • D3372

    Disodium Cycloheptylaminomethylene Diphosphate

    Bisphosphonate; squalene synthase inhibitor.
    ≥98%
  • A6132

    Apicidin

    Cyclic tetrapeptide; HDAC inhibitor.
    ≥98%
  • A5460

    A-type Natriuretic Peptide (1-11), rat

    Endogenous cardiomodulatory peptide; NPR-A agonist...
    ≥95%
  • S7701

    Stanozolol

    Synthetic anabolic steroid derived from dihydrotes...
    ≥98%
  • P0346

    Palosuran Hydrochloride

    Urotensin II receptor antagonist.
  • P0010

    Pituitary Adenylate Cyclase-activating Polypeptide-related Peptide, human

    Peptide, involved in paracrine and autocrine cell ...
    ≥95%
  • S6018

    Spectinomycin Dihydrochloride Pentahydrate

    Aminocyclitol; protein synthesis inhibitor.
    ≥603 µg/mg (potency)
  • D1759

    Deoxynivalenol

    Trichothecene mycotoxin produced by Fusarium.
    ≥98%, TLC
  • G1749

    Gemfibrozil

    Fibrate; PPARα agonist, enoyl-CoA reductase inhib...
    ≥98%
  • C3214

    CID-797718

    Potential PKD binding agent.
    ≥99%
  • Z2268

    Z-FR-AMC

    Protease substrate.
    ≥95%
  • B0133

    Baicalin

    Flavone found in Scutellaria; prolyl oligopeptidas...
    ≥95%
  • U6901

    Uracil

    Endogenous pyrimidine base required for production...
    ≥98%
  • P1760

    Peptide T

    Peptide fragment of HIV-1 gp120.
    ≥98%
  • S8014

    Substance P, Free Acid

    Endogenous tachykinin peptide, involved in inflamm...
    ≥95%
  • A5031

    4-Aminophenylphosphate Disodium

    4-Aminophenyl phosphate is an alkaline phosphatase...
    ≥98%
  • S1969

    Sermorelin Acetate

    Synthetic peptide, GHRH analog; GHRH agonist.
    ≥95%
  • N3323

    Nifuratel

    Nitrofuran derivative.
    ≥98%
  • C0029

    Cafestol Oleate

    Diterpene found in brewed, unfiltered coffee; FXR ...
    ≥98%
  • Z0944

    ZCL-278

    Cdc42 inhibitor.
    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only